Navigation Links
Highlights from BioMarin's Research & Development Day
Date:12/8/2011

>

  • Successful Type C meeting with FDA
  • Reduction in Phe is an acceptable primary endpoint for Phase III
  • Pivotal trial can be conducted in diet non compliant patients
  • Phase 2 Update
  • Weekly dosing (Part A and B): Good safety profile and substantial Phe reduction achieved in the majority of patients continuing in the study at a median maintenance dose of 1.0 mg/kg/week
  • Daily dosing (Part C): Initial rapid Phe reduction achieved in all patients but not sustained in the majority of patients; joint pain, fever and/or rash reliably ten days after study start
  • Initiating Part D of Phase 2 study to find the quickest and safest induction dosing regimen to an efficacious maintenance dose.  The optimal chronic regimen will be one subcutaneous injection per day.
  • Immunology Update
  • A daily dosing induction schedule leads to higher levels of anti PEG IgM titers and both higher and earlier PAL IgG titers compared to weekly dosing
  • Ways to attenuate the hypersensitivity reactions: Limit dosing when IgM responses are highest and titrate to efficacious doses once the IgG response has developed
  • Some patients do not mount a robust IgM Response to PEG and appear to have sustained efficacy and good tolerance
  • BMN-673 for Genetically-Defined Cancers

  • Dose escalation in Phase 1/2 study in solid tumors continuing after 5 steps (25-400 μg/once per day)
  • PK analysis is ongoing: Preliminary data indicate long terminal half-life
  • Once daily oral dosing is feasible
  • Preliminary results are encouraging in terms of toxicity and signs of efficacy
  • BMN-111 for Achondroplasia

  • Demonstrated benefits in moderately and severely affected animal models
  • Positive therapeutic index predicted in vivo
  • Phase 1 clinical trial in healthy volunteers to begin 1Q 2012
  • Phase 2 proof of concept trial in affected pedi
    '/>"/>

  • SOURCE BioMarin Pharmaceutical Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
    2. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
    3. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
    4. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
    5. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
    6. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
    7. Research Highlights Potential Benefits of Telemedicine in Treating Eye Disease
    8. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research
    9. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
    10. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
    11. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/31/2014)... 30, 2014 ... addition of the  "Process Validation in the US ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,Key topics ... Based Approach to Process Validation for Pharmaceutical and ... FDA Process Validation Guidance EU ...
    (Date:10/31/2014)... 31, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ... , Isis Pharmaceuticals, Third Quarter 2014 Financial Results ... at 11:30 a.m. ET / 8:30 a.m. PTWhere: ... Internet. Simply log onto our website listed above. If ... a replay of the webcast will be available for ...
    (Date:10/31/2014)... Ill., Oct. 31, 2014  AbbVie (NYSE: ... the third quarter ended Sept. 30, 2014. ... performance of our business with double-digit growth from ... business grew nearly 14 percent in the quarter ... chief executive officer, AbbVie.  "We exceeded our outlook ...
    Breaking Medicine Technology:Process Validation in the US and EU (Workshop, London) 2Process Validation in the US and EU (Workshop, London) 3Process Validation in the US and EU (Workshop, London) 4Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 2Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 3AbbVie Reports Third-Quarter 2014 Financial Results 2AbbVie Reports Third-Quarter 2014 Financial Results 3AbbVie Reports Third-Quarter 2014 Financial Results 4AbbVie Reports Third-Quarter 2014 Financial Results 5AbbVie Reports Third-Quarter 2014 Financial Results 6AbbVie Reports Third-Quarter 2014 Financial Results 7AbbVie Reports Third-Quarter 2014 Financial Results 8AbbVie Reports Third-Quarter 2014 Financial Results 9AbbVie Reports Third-Quarter 2014 Financial Results 10AbbVie Reports Third-Quarter 2014 Financial Results 11AbbVie Reports Third-Quarter 2014 Financial Results 12AbbVie Reports Third-Quarter 2014 Financial Results 13AbbVie Reports Third-Quarter 2014 Financial Results 14AbbVie Reports Third-Quarter 2014 Financial Results 15AbbVie Reports Third-Quarter 2014 Financial Results 16AbbVie Reports Third-Quarter 2014 Financial Results 17AbbVie Reports Third-Quarter 2014 Financial Results 18AbbVie Reports Third-Quarter 2014 Financial Results 19AbbVie Reports Third-Quarter 2014 Financial Results 20AbbVie Reports Third-Quarter 2014 Financial Results 21AbbVie Reports Third-Quarter 2014 Financial Results 22AbbVie Reports Third-Quarter 2014 Financial Results 23AbbVie Reports Third-Quarter 2014 Financial Results 24
    (Date:10/31/2014)... Hopkins engineers have invented a lab device to give ... complex way that tumor cells spread through the body, ... shedding light on precisely how tumor cells travel, the ... check. , The inventors, from the university,s Whiting School ... details and images from their new system recently in ...
    (Date:10/31/2014)... 2014 North Shore Eye Care today ... Long Island and the addition of leading ophthalmologist, William ... to North Shore Eye Care Medical Director, Jeffrey Martin, ... of the Department of Ophthalmology of Winthrop-University Hospital and ... City for more than 30 years. He has been ...
    (Date:10/31/2014)... 31, 2014 Florida Air Academy, ... girls in grades 6-12, is taking the lead ... injuries and concussions, becoming the first high school ... (Immediate Post-Concussion Assessment and Cognitive Testing) computerized assessment ... Player' lawsuit grabs the headlines, and the Centers ...
    (Date:10/31/2014)... 2014 Triple Board Certified surgeon ... services to transform the appearance of military veteran Joseph ... of Facial Plastic and Reconstruction Surgery (AAFPRS) Faces of ... the facial hair Jones lost during an IED blast ... hair restoration procedure, valued around $16,000, took Dr. Epstein ...
    (Date:10/31/2014)... October 31, 2014 Uniwigs.com newly arrived ... The new model can comfortably attach itself around people’s heads ... This new generation of flip-in extensions comes with adjustable loops, ... the wire part and customers can now adjust the wire ... , When people apply this new generation of flip ins, ...
    Breaking Medicine News(10 mins):Health News:Viewing cancer on the move: New device yields close-up look at metastasis 2Health News:Viewing cancer on the move: New device yields close-up look at metastasis 3Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 3Health News:Florida Air Academy Tackling Concussions Head-On 2Health News:Florida Air Academy Tackling Concussions Head-On 3Health News:Miami Hair Restoration Specialist Transforms Wounded Soldier 2Health News:UniWigs Unveiles New Generation of Flip In Hair Extensions 2
    ... Over Q1 2008VANCOUVER, April 20 /PRNewswire-FirstCall/ - Response ... preliminary unaudited revenues for the three-month period ended ... to approximately $2.526 million compared to $1.173 million ... the highest revenues for any quarter in the ...
    ... Intervention Will Retain Decision Resources, Clinical Gold Standard ... from Decision ResourcesWALTHAM, Mass., April 20 Decision ... advisory firms for pharmaceutical and healthcare issues, finds ... mortality as the attribute that most influences their ...
    ... Mix Featuring Arthur and Friends , BURLINGTON, Mass. ... Cherrybrook Kitchen, the brand known for allergy-friendly desserts and ... Arthur, the award-winning PBS character whose TV show entertains ... challenges, lessons and obstacles of growing up. Launched in ...
    ... largest Italian American Service Organization in the United States, ... Awardees will be honored at the 87th Annual UNICO ... Americanism Award: Grand Order Filippo Mazzei ... of the Adopt a Soldier Platoon Cianci Humanitarian ...
    ... Leukemia & Lymphoma SocietyWHITE PLAINS, N.Y., April 20 For ... perform on behalf of their children and other loved ones ... special to pay tribute to mothers.Consider the heroic gesture performed ... more terrifying for a mother than to watch helplessly as ...
    ... To Sleep products so much, we bought the company"MILWAUKEE, ... today that ICP has acquired Scent To Sleep - ... a revolutionary All Natural Non-Drowsy Sleep Mist ( www.ScentToSleep.com ... To Sleep products so much, we bought the company. ...
    Cached Medicine News:Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 2Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 3Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 4Health News:For Reducing Mortality, Current and Emerging Therapies Have No Advantage Over Carvedilol in the Treatment of Coronary Heart Disease (Stable Angina) 2Health News:For Reducing Mortality, Current and Emerging Therapies Have No Advantage Over Carvedilol in the Treatment of Coronary Heart Disease (Stable Angina) 3Health News:Cherrybrook Kitchen Announces New Partnership With Arthur 2Health News:Cherrybrook Kitchen Announces New Partnership With Arthur 3Health News:UNICO National Announces 2009 Award Winners 2Health News:UNICO National Announces 2009 Award Winners 3Health News:This Mother's Day Celebrate a Mother's Love 2Health News:Scent To Sleep All Natural Non-Drowsy Sleep Mist Acquired by Innovative Custom Products, Inc. (ICP) 2
    An easy-to-fit high water content spherical soft lens manufactured using cast molding technology, and designed for use in the correction of myopia on a daily wear or extended wear basis....
    Bausch & Lomb SofLens59 contact lenses combine excellent performance, comfort and visual acuity providing daily wear for two week replacement....
    ... uses reflection mirrors to measure the ... after tumor removal or thyroid decompression. ... Naugle is easy to handle- with ... and plastic mounts that are placed ...
    Hertel exophthalmometer is used for precise exophthalmos measurements (e.g. exophthalmic goiter)....
    Medicine Products: